Latest filing published 07 Mar 2011 for Interpace Biosciences, INC., €108k.
Insider track record
No signal scores available.
David E. Kerr: trading record in brief
David E. Kerr is a declared insider of Interpace Biosciences, Inc., with filings sourced from SEC (Form 4). Between 1 March 2010 and 3 March 2011, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 7 March 2011, the filings show a share grant worth €108k in Interpace Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David E. Kerr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,773 shares@ US$8.44Common StockSEC:0001140361-11-014879:0
- 225 shares@ US$10.98Common StockSEC:0001140361-10-051436:0
- 2,277 shares@ US$10.98Common StockSEC:0001140361-10-051132:0
- 8,946 shares@ US$5.03Common StockSEC:0001140361-10-010576:0
4 of 4 declarations